Global Piroxicam Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
LPI (LP Information)' newest research report, the “Piroxicam Industry Forecast” looks at past sales and reviews total world Piroxicam sales in 2022, providing a comprehensive analysis by region and market sector of projected Piroxicam sales for 2023 through 2029. With Piroxicam sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piroxicam industry.
This Insight Report provides a comprehensive analysis of the global Piroxicam landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Piroxicam portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Piroxicam market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piroxicam and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piroxicam.
The global Piroxicam market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Piroxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Piroxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Piroxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Piroxicam players cover Pfizer, Teva, Mylan, Nostrum, DCPC, FANGMING, JINGHUA, JUMPCAN and Technilab Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Piroxicam market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
LPI (LP Information)' newest research report, the “Piroxicam Industry Forecast” looks at past sales and reviews total world Piroxicam sales in 2022, providing a comprehensive analysis by region and market sector of projected Piroxicam sales for 2023 through 2029. With Piroxicam sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piroxicam industry.
This Insight Report provides a comprehensive analysis of the global Piroxicam landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Piroxicam portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Piroxicam market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piroxicam and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piroxicam.
The global Piroxicam market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Piroxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Piroxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Piroxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Piroxicam players cover Pfizer, Teva, Mylan, Nostrum, DCPC, FANGMING, JINGHUA, JUMPCAN and Technilab Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Piroxicam market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- by Dosage Form
- Suppositories
- Injection
- Capsule
- Patch
- Other
- by Route
- Oral
- Rectal
- Tendonitis
- Systemic Traumatic Pain
- Musculoskeletal Pain
- Contraception
- Rheumatoid Arthritis
- Chronic Infectious Arthritis
- Osteoarthritis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva
- Mylan
- Nostrum
- DCPC
- FANGMING
- JINGHUA
- JUMPCAN
- Technilab Pharma
- Apotex Corporation
- Keltman Pharmaceuticals
- Genpharm
- Bayer
- PLX Pharma
- Chiesi
- SK Chemicals
- Bioglan Laboratories
- APR
- CJ HealthCare
- SkyePharma
- Changzhou Siyao Pharmaceutical
- Shanxi Yunpeng Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Piroxicam Market Size 2018-2029
2.1.2 Piroxicam Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Piroxicam Segment by Type
2.2.1 Suppositories
2.2.2 Injection
2.2.3 Capsule
2.2.4 Patch
2.2.5 Other
2.3 Piroxicam Market Size by Type
2.3.1 Piroxicam Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Piroxicam Market Size Market Share by Type (2018-2023)
2.4 Piroxicam Segment by Application
2.4.1 Tendonitis
2.4.2 Systemic Traumatic Pain
2.4.3 Musculoskeletal Pain
2.4.4 Contraception
2.4.5 Rheumatoid Arthritis
2.4.6 Chronic Infectious Arthritis
2.4.7 Osteoarthritis
2.4.8 Other
2.5 Piroxicam Market Size by Application
2.5.1 Piroxicam Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Piroxicam Market Size Market Share by Application (2018-2023)
3 PIROXICAM MARKET SIZE BY PLAYER
3.1 Piroxicam Market Size Market Share by Players
3.1.1 Global Piroxicam Revenue by Players (2018-2023)
3.1.2 Global Piroxicam Revenue Market Share by Players (2018-2023)
3.2 Global Piroxicam Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PIROXICAM BY REGIONS
4.1 Piroxicam Market Size by Regions (2018-2023)
4.2 Americas Piroxicam Market Size Growth (2018-2023)
4.3 APAC Piroxicam Market Size Growth (2018-2023)
4.4 Europe Piroxicam Market Size Growth (2018-2023)
4.5 Middle East & Africa Piroxicam Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Piroxicam Market Size by Country (2018-2023)
5.2 Americas Piroxicam Market Size by Type (2018-2023)
5.3 Americas Piroxicam Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piroxicam Market Size by Region (2018-2023)
6.2 APAC Piroxicam Market Size by Type (2018-2023)
6.3 APAC Piroxicam Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Piroxicam by Country (2018-2023)
7.2 Europe Piroxicam Market Size by Type (2018-2023)
7.3 Europe Piroxicam Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Piroxicam by Region (2018-2023)
8.2 Middle East & Africa Piroxicam Market Size by Type (2018-2023)
8.3 Middle East & Africa Piroxicam Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PIROXICAM MARKET FORECAST
10.1 Global Piroxicam Forecast by Regions (2024-2029)
10.1.1 Global Piroxicam Forecast by Regions (2024-2029)
10.1.2 Americas Piroxicam Forecast
10.1.3 APAC Piroxicam Forecast
10.1.4 Europe Piroxicam Forecast
10.1.5 Middle East & Africa Piroxicam Forecast
10.2 Americas Piroxicam Forecast by Country (2024-2029)
10.2.1 United States Piroxicam Market Forecast
10.2.2 Canada Piroxicam Market Forecast
10.2.3 Mexico Piroxicam Market Forecast
10.2.4 Brazil Piroxicam Market Forecast
10.3 APAC Piroxicam Forecast by Region (2024-2029)
10.3.1 China Piroxicam Market Forecast
10.3.2 Japan Piroxicam Market Forecast
10.3.3 Korea Piroxicam Market Forecast
10.3.4 Southeast Asia Piroxicam Market Forecast
10.3.5 India Piroxicam Market Forecast
10.3.6 Australia Piroxicam Market Forecast
10.4 Europe Piroxicam Forecast by Country (2024-2029)
10.4.1 Germany Piroxicam Market Forecast
10.4.2 France Piroxicam Market Forecast
10.4.3 UK Piroxicam Market Forecast
10.4.4 Italy Piroxicam Market Forecast
10.4.5 Russia Piroxicam Market Forecast
10.5 Middle East & Africa Piroxicam Forecast by Region (2024-2029)
10.5.1 Egypt Piroxicam Market Forecast
10.5.2 South Africa Piroxicam Market Forecast
10.5.3 Israel Piroxicam Market Forecast
10.5.4 Turkey Piroxicam Market Forecast
10.5.5 GCC Countries Piroxicam Market Forecast
10.6 Global Piroxicam Forecast by Type (2024-2029)
10.7 Global Piroxicam Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Piroxicam Product Offered
11.1.3 Pfizer Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Piroxicam Product Offered
11.2.3 Teva Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Piroxicam Product Offered
11.3.3 Mylan Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Nostrum
11.4.1 Nostrum Company Information
11.4.2 Nostrum Piroxicam Product Offered
11.4.3 Nostrum Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Nostrum Main Business Overview
11.4.5 Nostrum Latest Developments
11.5 DCPC
11.5.1 DCPC Company Information
11.5.2 DCPC Piroxicam Product Offered
11.5.3 DCPC Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 DCPC Main Business Overview
11.5.5 DCPC Latest Developments
11.6 FANGMING
11.6.1 FANGMING Company Information
11.6.2 FANGMING Piroxicam Product Offered
11.6.3 FANGMING Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 FANGMING Main Business Overview
11.6.5 FANGMING Latest Developments
11.7 JINGHUA
11.7.1 JINGHUA Company Information
11.7.2 JINGHUA Piroxicam Product Offered
11.7.3 JINGHUA Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 JINGHUA Main Business Overview
11.7.5 JINGHUA Latest Developments
11.8 JUMPCAN
11.8.1 JUMPCAN Company Information
11.8.2 JUMPCAN Piroxicam Product Offered
11.8.3 JUMPCAN Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 JUMPCAN Main Business Overview
11.8.5 JUMPCAN Latest Developments
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Information
11.9.2 Technilab Pharma Piroxicam Product Offered
11.9.3 Technilab Pharma Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Technilab Pharma Main Business Overview
11.9.5 Technilab Pharma Latest Developments
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Information
11.10.2 Apotex Corporation Piroxicam Product Offered
11.10.3 Apotex Corporation Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Apotex Corporation Main Business Overview
11.10.5 Apotex Corporation Latest Developments
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Information
11.11.2 Keltman Pharmaceuticals Piroxicam Product Offered
11.11.3 Keltman Pharmaceuticals Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Keltman Pharmaceuticals Main Business Overview
11.11.5 Keltman Pharmaceuticals Latest Developments
11.12 Genpharm
11.12.1 Genpharm Company Information
11.12.2 Genpharm Piroxicam Product Offered
11.12.3 Genpharm Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Genpharm Main Business Overview
11.12.5 Genpharm Latest Developments
11.13 Bayer
11.13.1 Bayer Company Information
11.13.2 Bayer Piroxicam Product Offered
11.13.3 Bayer Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Bayer Main Business Overview
11.13.5 Bayer Latest Developments
11.14 PLX Pharma
11.14.1 PLX Pharma Company Information
11.14.2 PLX Pharma Piroxicam Product Offered
11.14.3 PLX Pharma Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 PLX Pharma Main Business Overview
11.14.5 PLX Pharma Latest Developments
11.15 Chiesi
11.15.1 Chiesi Company Information
11.15.2 Chiesi Piroxicam Product Offered
11.15.3 Chiesi Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Chiesi Main Business Overview
11.15.5 Chiesi Latest Developments
11.16 SK Chemicals
11.16.1 SK Chemicals Company Information
11.16.2 SK Chemicals Piroxicam Product Offered
11.16.3 SK Chemicals Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 SK Chemicals Main Business Overview
11.16.5 SK Chemicals Latest Developments
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Information
11.17.2 Bioglan Laboratories Piroxicam Product Offered
11.17.3 Bioglan Laboratories Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Bioglan Laboratories Main Business Overview
11.17.5 Bioglan Laboratories Latest Developments
11.18 APR
11.18.1 APR Company Information
11.18.2 APR Piroxicam Product Offered
11.18.3 APR Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 APR Main Business Overview
11.18.5 APR Latest Developments
11.19 CJ HealthCare
11.19.1 CJ HealthCare Company Information
11.19.2 CJ HealthCare Piroxicam Product Offered
11.19.3 CJ HealthCare Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 CJ HealthCare Main Business Overview
11.19.5 CJ HealthCare Latest Developments
11.20 SkyePharma
11.20.1 SkyePharma Company Information
11.20.2 SkyePharma Piroxicam Product Offered
11.20.3 SkyePharma Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 SkyePharma Main Business Overview
11.20.5 SkyePharma Latest Developments
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Information
11.21.2 Changzhou Siyao Pharmaceutical Piroxicam Product Offered
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Changzhou Siyao Pharmaceutical Main Business Overview
11.21.5 Changzhou Siyao Pharmaceutical Latest Developments
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Information
11.22.2 Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Shanxi Yunpeng Pharmaceutical Main Business Overview
11.22.5 Shanxi Yunpeng Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Piroxicam Market Size 2018-2029
2.1.2 Piroxicam Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Piroxicam Segment by Type
2.2.1 Suppositories
2.2.2 Injection
2.2.3 Capsule
2.2.4 Patch
2.2.5 Other
2.3 Piroxicam Market Size by Type
2.3.1 Piroxicam Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Piroxicam Market Size Market Share by Type (2018-2023)
2.4 Piroxicam Segment by Application
2.4.1 Tendonitis
2.4.2 Systemic Traumatic Pain
2.4.3 Musculoskeletal Pain
2.4.4 Contraception
2.4.5 Rheumatoid Arthritis
2.4.6 Chronic Infectious Arthritis
2.4.7 Osteoarthritis
2.4.8 Other
2.5 Piroxicam Market Size by Application
2.5.1 Piroxicam Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Piroxicam Market Size Market Share by Application (2018-2023)
3 PIROXICAM MARKET SIZE BY PLAYER
3.1 Piroxicam Market Size Market Share by Players
3.1.1 Global Piroxicam Revenue by Players (2018-2023)
3.1.2 Global Piroxicam Revenue Market Share by Players (2018-2023)
3.2 Global Piroxicam Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PIROXICAM BY REGIONS
4.1 Piroxicam Market Size by Regions (2018-2023)
4.2 Americas Piroxicam Market Size Growth (2018-2023)
4.3 APAC Piroxicam Market Size Growth (2018-2023)
4.4 Europe Piroxicam Market Size Growth (2018-2023)
4.5 Middle East & Africa Piroxicam Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Piroxicam Market Size by Country (2018-2023)
5.2 Americas Piroxicam Market Size by Type (2018-2023)
5.3 Americas Piroxicam Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piroxicam Market Size by Region (2018-2023)
6.2 APAC Piroxicam Market Size by Type (2018-2023)
6.3 APAC Piroxicam Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Piroxicam by Country (2018-2023)
7.2 Europe Piroxicam Market Size by Type (2018-2023)
7.3 Europe Piroxicam Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Piroxicam by Region (2018-2023)
8.2 Middle East & Africa Piroxicam Market Size by Type (2018-2023)
8.3 Middle East & Africa Piroxicam Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PIROXICAM MARKET FORECAST
10.1 Global Piroxicam Forecast by Regions (2024-2029)
10.1.1 Global Piroxicam Forecast by Regions (2024-2029)
10.1.2 Americas Piroxicam Forecast
10.1.3 APAC Piroxicam Forecast
10.1.4 Europe Piroxicam Forecast
10.1.5 Middle East & Africa Piroxicam Forecast
10.2 Americas Piroxicam Forecast by Country (2024-2029)
10.2.1 United States Piroxicam Market Forecast
10.2.2 Canada Piroxicam Market Forecast
10.2.3 Mexico Piroxicam Market Forecast
10.2.4 Brazil Piroxicam Market Forecast
10.3 APAC Piroxicam Forecast by Region (2024-2029)
10.3.1 China Piroxicam Market Forecast
10.3.2 Japan Piroxicam Market Forecast
10.3.3 Korea Piroxicam Market Forecast
10.3.4 Southeast Asia Piroxicam Market Forecast
10.3.5 India Piroxicam Market Forecast
10.3.6 Australia Piroxicam Market Forecast
10.4 Europe Piroxicam Forecast by Country (2024-2029)
10.4.1 Germany Piroxicam Market Forecast
10.4.2 France Piroxicam Market Forecast
10.4.3 UK Piroxicam Market Forecast
10.4.4 Italy Piroxicam Market Forecast
10.4.5 Russia Piroxicam Market Forecast
10.5 Middle East & Africa Piroxicam Forecast by Region (2024-2029)
10.5.1 Egypt Piroxicam Market Forecast
10.5.2 South Africa Piroxicam Market Forecast
10.5.3 Israel Piroxicam Market Forecast
10.5.4 Turkey Piroxicam Market Forecast
10.5.5 GCC Countries Piroxicam Market Forecast
10.6 Global Piroxicam Forecast by Type (2024-2029)
10.7 Global Piroxicam Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Piroxicam Product Offered
11.1.3 Pfizer Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Piroxicam Product Offered
11.2.3 Teva Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Piroxicam Product Offered
11.3.3 Mylan Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Nostrum
11.4.1 Nostrum Company Information
11.4.2 Nostrum Piroxicam Product Offered
11.4.3 Nostrum Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Nostrum Main Business Overview
11.4.5 Nostrum Latest Developments
11.5 DCPC
11.5.1 DCPC Company Information
11.5.2 DCPC Piroxicam Product Offered
11.5.3 DCPC Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 DCPC Main Business Overview
11.5.5 DCPC Latest Developments
11.6 FANGMING
11.6.1 FANGMING Company Information
11.6.2 FANGMING Piroxicam Product Offered
11.6.3 FANGMING Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 FANGMING Main Business Overview
11.6.5 FANGMING Latest Developments
11.7 JINGHUA
11.7.1 JINGHUA Company Information
11.7.2 JINGHUA Piroxicam Product Offered
11.7.3 JINGHUA Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 JINGHUA Main Business Overview
11.7.5 JINGHUA Latest Developments
11.8 JUMPCAN
11.8.1 JUMPCAN Company Information
11.8.2 JUMPCAN Piroxicam Product Offered
11.8.3 JUMPCAN Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 JUMPCAN Main Business Overview
11.8.5 JUMPCAN Latest Developments
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Information
11.9.2 Technilab Pharma Piroxicam Product Offered
11.9.3 Technilab Pharma Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Technilab Pharma Main Business Overview
11.9.5 Technilab Pharma Latest Developments
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Information
11.10.2 Apotex Corporation Piroxicam Product Offered
11.10.3 Apotex Corporation Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Apotex Corporation Main Business Overview
11.10.5 Apotex Corporation Latest Developments
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Information
11.11.2 Keltman Pharmaceuticals Piroxicam Product Offered
11.11.3 Keltman Pharmaceuticals Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Keltman Pharmaceuticals Main Business Overview
11.11.5 Keltman Pharmaceuticals Latest Developments
11.12 Genpharm
11.12.1 Genpharm Company Information
11.12.2 Genpharm Piroxicam Product Offered
11.12.3 Genpharm Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Genpharm Main Business Overview
11.12.5 Genpharm Latest Developments
11.13 Bayer
11.13.1 Bayer Company Information
11.13.2 Bayer Piroxicam Product Offered
11.13.3 Bayer Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Bayer Main Business Overview
11.13.5 Bayer Latest Developments
11.14 PLX Pharma
11.14.1 PLX Pharma Company Information
11.14.2 PLX Pharma Piroxicam Product Offered
11.14.3 PLX Pharma Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 PLX Pharma Main Business Overview
11.14.5 PLX Pharma Latest Developments
11.15 Chiesi
11.15.1 Chiesi Company Information
11.15.2 Chiesi Piroxicam Product Offered
11.15.3 Chiesi Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Chiesi Main Business Overview
11.15.5 Chiesi Latest Developments
11.16 SK Chemicals
11.16.1 SK Chemicals Company Information
11.16.2 SK Chemicals Piroxicam Product Offered
11.16.3 SK Chemicals Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 SK Chemicals Main Business Overview
11.16.5 SK Chemicals Latest Developments
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Information
11.17.2 Bioglan Laboratories Piroxicam Product Offered
11.17.3 Bioglan Laboratories Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Bioglan Laboratories Main Business Overview
11.17.5 Bioglan Laboratories Latest Developments
11.18 APR
11.18.1 APR Company Information
11.18.2 APR Piroxicam Product Offered
11.18.3 APR Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 APR Main Business Overview
11.18.5 APR Latest Developments
11.19 CJ HealthCare
11.19.1 CJ HealthCare Company Information
11.19.2 CJ HealthCare Piroxicam Product Offered
11.19.3 CJ HealthCare Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 CJ HealthCare Main Business Overview
11.19.5 CJ HealthCare Latest Developments
11.20 SkyePharma
11.20.1 SkyePharma Company Information
11.20.2 SkyePharma Piroxicam Product Offered
11.20.3 SkyePharma Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 SkyePharma Main Business Overview
11.20.5 SkyePharma Latest Developments
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Information
11.21.2 Changzhou Siyao Pharmaceutical Piroxicam Product Offered
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Changzhou Siyao Pharmaceutical Main Business Overview
11.21.5 Changzhou Siyao Pharmaceutical Latest Developments
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Information
11.22.2 Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Shanxi Yunpeng Pharmaceutical Main Business Overview
11.22.5 Shanxi Yunpeng Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Piroxicam Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Suppositories
Table 3. Major Players of Injection
Table 4. Major Players of Capsule
Table 5. Major Players of Patch
Table 6. Major Players of Other
Table 7. Piroxicam Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Piroxicam Market Size Market Share by Type (2018-2023)
Table 10. Piroxicam Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Piroxicam Market Size Market Share by Application (2018-2023)
Table 13. Global Piroxicam Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Piroxicam Revenue Market Share by Player (2018-2023)
Table 15. Piroxicam Key Players Head office and Products Offered
Table 16. Piroxicam Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Piroxicam Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Piroxicam Market Size Market Share by Regions (2018-2023)
Table 21. Global Piroxicam Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Piroxicam Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Piroxicam Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Piroxicam Market Size Market Share by Country (2018-2023)
Table 25. Americas Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Piroxicam Market Size Market Share by Type (2018-2023)
Table 27. Americas Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Piroxicam Market Size Market Share by Application (2018-2023)
Table 29. APAC Piroxicam Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Piroxicam Market Size Market Share by Region (2018-2023)
Table 31. APAC Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Piroxicam Market Size Market Share by Type (2018-2023)
Table 33. APAC Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Piroxicam Market Size Market Share by Application (2018-2023)
Table 35. Europe Piroxicam Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Piroxicam Market Size Market Share by Country (2018-2023)
Table 37. Europe Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Piroxicam Market Size Market Share by Type (2018-2023)
Table 39. Europe Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Piroxicam Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Piroxicam Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Piroxicam Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Piroxicam Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Piroxicam Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Piroxicam
Table 48. Key Market Challenges & Risks of Piroxicam
Table 49. Key Industry Trends of Piroxicam
Table 50. Global Piroxicam Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Piroxicam Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Piroxicam Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Piroxicam Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Pfizer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 55. Pfizer Piroxicam Product Offered
Table 56. Pfizer Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Main Business
Table 58. Pfizer Latest Developments
Table 59. Teva Details, Company Type, Piroxicam Area Served and Its Competitors
Table 60. Teva Piroxicam Product Offered
Table 61. Teva Main Business
Table 62. Teva Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Teva Latest Developments
Table 64. Mylan Details, Company Type, Piroxicam Area Served and Its Competitors
Table 65. Mylan Piroxicam Product Offered
Table 66. Mylan Main Business
Table 67. Mylan Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Mylan Latest Developments
Table 69. Nostrum Details, Company Type, Piroxicam Area Served and Its Competitors
Table 70. Nostrum Piroxicam Product Offered
Table 71. Nostrum Main Business
Table 72. Nostrum Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Nostrum Latest Developments
Table 74. DCPC Details, Company Type, Piroxicam Area Served and Its Competitors
Table 75. DCPC Piroxicam Product Offered
Table 76. DCPC Main Business
Table 77. DCPC Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. DCPC Latest Developments
Table 79. FANGMING Details, Company Type, Piroxicam Area Served and Its Competitors
Table 80. FANGMING Piroxicam Product Offered
Table 81. FANGMING Main Business
Table 82. FANGMING Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. FANGMING Latest Developments
Table 84. JINGHUA Details, Company Type, Piroxicam Area Served and Its Competitors
Table 85. JINGHUA Piroxicam Product Offered
Table 86. JINGHUA Main Business
Table 87. JINGHUA Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. JINGHUA Latest Developments
Table 89. JUMPCAN Details, Company Type, Piroxicam Area Served and Its Competitors
Table 90. JUMPCAN Piroxicam Product Offered
Table 91. JUMPCAN Main Business
Table 92. JUMPCAN Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. JUMPCAN Latest Developments
Table 94. Technilab Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 95. Technilab Pharma Piroxicam Product Offered
Table 96. Technilab Pharma Main Business
Table 97. Technilab Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Technilab Pharma Latest Developments
Table 99. Apotex Corporation Details, Company Type, Piroxicam Area Served and Its Competitors
Table 100. Apotex Corporation Piroxicam Product Offered
Table 101. Apotex Corporation Main Business
Table 102. Apotex Corporation Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Apotex Corporation Latest Developments
Table 104. Keltman Pharmaceuticals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 105. Keltman Pharmaceuticals Piroxicam Product Offered
Table 106. Keltman Pharmaceuticals Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Keltman Pharmaceuticals Main Business
Table 108. Keltman Pharmaceuticals Latest Developments
Table 109. Genpharm Details, Company Type, Piroxicam Area Served and Its Competitors
Table 110. Genpharm Piroxicam Product Offered
Table 111. Genpharm Main Business
Table 112. Genpharm Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Genpharm Latest Developments
Table 114. Bayer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 115. Bayer Piroxicam Product Offered
Table 116. Bayer Main Business
Table 117. Bayer Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Bayer Latest Developments
Table 119. PLX Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 120. PLX Pharma Piroxicam Product Offered
Table 121. PLX Pharma Main Business
Table 122. PLX Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. PLX Pharma Latest Developments
Table 124. Chiesi Details, Company Type, Piroxicam Area Served and Its Competitors
Table 125. Chiesi Piroxicam Product Offered
Table 126. Chiesi Main Business
Table 127. Chiesi Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Chiesi Latest Developments
Table 129. SK Chemicals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 130. SK Chemicals Piroxicam Product Offered
Table 131. SK Chemicals Main Business
Table 132. SK Chemicals Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. SK Chemicals Latest Developments
Table 134. Bioglan Laboratories Details, Company Type, Piroxicam Area Served and Its Competitors
Table 135. Bioglan Laboratories Piroxicam Product Offered
Table 136. Bioglan Laboratories Main Business
Table 137. Bioglan Laboratories Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Bioglan Laboratories Latest Developments
Table 139. APR Details, Company Type, Piroxicam Area Served and Its Competitors
Table 140. APR Piroxicam Product Offered
Table 141. APR Main Business
Table 142. APR Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. APR Latest Developments
Table 144. CJ HealthCare Details, Company Type, Piroxicam Area Served and Its Competitors
Table 145. CJ HealthCare Piroxicam Product Offered
Table 146. CJ HealthCare Main Business
Table 147. CJ HealthCare Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. CJ HealthCare Latest Developments
Table 149. SkyePharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 150. SkyePharma Piroxicam Product Offered
Table 151. SkyePharma Main Business
Table 152. SkyePharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. SkyePharma Latest Developments
Table 154. Changzhou Siyao Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 155. Changzhou Siyao Pharmaceutical Piroxicam Product Offered
Table 156. Changzhou Siyao Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. Changzhou Siyao Pharmaceutical Main Business
Table 158. Changzhou Siyao Pharmaceutical Latest Developments
Table 159. Shanxi Yunpeng Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 160. Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
Table 161. Shanxi Yunpeng Pharmaceutical Main Business
Table 162. Shanxi Yunpeng Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 163. Shanxi Yunpeng Pharmaceutical Latest Developments
Table 1. Piroxicam Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Suppositories
Table 3. Major Players of Injection
Table 4. Major Players of Capsule
Table 5. Major Players of Patch
Table 6. Major Players of Other
Table 7. Piroxicam Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Piroxicam Market Size Market Share by Type (2018-2023)
Table 10. Piroxicam Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Piroxicam Market Size Market Share by Application (2018-2023)
Table 13. Global Piroxicam Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Piroxicam Revenue Market Share by Player (2018-2023)
Table 15. Piroxicam Key Players Head office and Products Offered
Table 16. Piroxicam Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Piroxicam Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Piroxicam Market Size Market Share by Regions (2018-2023)
Table 21. Global Piroxicam Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Piroxicam Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Piroxicam Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Piroxicam Market Size Market Share by Country (2018-2023)
Table 25. Americas Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Piroxicam Market Size Market Share by Type (2018-2023)
Table 27. Americas Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Piroxicam Market Size Market Share by Application (2018-2023)
Table 29. APAC Piroxicam Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Piroxicam Market Size Market Share by Region (2018-2023)
Table 31. APAC Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Piroxicam Market Size Market Share by Type (2018-2023)
Table 33. APAC Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Piroxicam Market Size Market Share by Application (2018-2023)
Table 35. Europe Piroxicam Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Piroxicam Market Size Market Share by Country (2018-2023)
Table 37. Europe Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Piroxicam Market Size Market Share by Type (2018-2023)
Table 39. Europe Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Piroxicam Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Piroxicam Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Piroxicam Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Piroxicam Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Piroxicam Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Piroxicam Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Piroxicam Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Piroxicam
Table 48. Key Market Challenges & Risks of Piroxicam
Table 49. Key Industry Trends of Piroxicam
Table 50. Global Piroxicam Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Piroxicam Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Piroxicam Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Piroxicam Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Pfizer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 55. Pfizer Piroxicam Product Offered
Table 56. Pfizer Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Main Business
Table 58. Pfizer Latest Developments
Table 59. Teva Details, Company Type, Piroxicam Area Served and Its Competitors
Table 60. Teva Piroxicam Product Offered
Table 61. Teva Main Business
Table 62. Teva Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Teva Latest Developments
Table 64. Mylan Details, Company Type, Piroxicam Area Served and Its Competitors
Table 65. Mylan Piroxicam Product Offered
Table 66. Mylan Main Business
Table 67. Mylan Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Mylan Latest Developments
Table 69. Nostrum Details, Company Type, Piroxicam Area Served and Its Competitors
Table 70. Nostrum Piroxicam Product Offered
Table 71. Nostrum Main Business
Table 72. Nostrum Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Nostrum Latest Developments
Table 74. DCPC Details, Company Type, Piroxicam Area Served and Its Competitors
Table 75. DCPC Piroxicam Product Offered
Table 76. DCPC Main Business
Table 77. DCPC Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. DCPC Latest Developments
Table 79. FANGMING Details, Company Type, Piroxicam Area Served and Its Competitors
Table 80. FANGMING Piroxicam Product Offered
Table 81. FANGMING Main Business
Table 82. FANGMING Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. FANGMING Latest Developments
Table 84. JINGHUA Details, Company Type, Piroxicam Area Served and Its Competitors
Table 85. JINGHUA Piroxicam Product Offered
Table 86. JINGHUA Main Business
Table 87. JINGHUA Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. JINGHUA Latest Developments
Table 89. JUMPCAN Details, Company Type, Piroxicam Area Served and Its Competitors
Table 90. JUMPCAN Piroxicam Product Offered
Table 91. JUMPCAN Main Business
Table 92. JUMPCAN Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. JUMPCAN Latest Developments
Table 94. Technilab Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 95. Technilab Pharma Piroxicam Product Offered
Table 96. Technilab Pharma Main Business
Table 97. Technilab Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Technilab Pharma Latest Developments
Table 99. Apotex Corporation Details, Company Type, Piroxicam Area Served and Its Competitors
Table 100. Apotex Corporation Piroxicam Product Offered
Table 101. Apotex Corporation Main Business
Table 102. Apotex Corporation Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Apotex Corporation Latest Developments
Table 104. Keltman Pharmaceuticals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 105. Keltman Pharmaceuticals Piroxicam Product Offered
Table 106. Keltman Pharmaceuticals Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Keltman Pharmaceuticals Main Business
Table 108. Keltman Pharmaceuticals Latest Developments
Table 109. Genpharm Details, Company Type, Piroxicam Area Served and Its Competitors
Table 110. Genpharm Piroxicam Product Offered
Table 111. Genpharm Main Business
Table 112. Genpharm Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Genpharm Latest Developments
Table 114. Bayer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 115. Bayer Piroxicam Product Offered
Table 116. Bayer Main Business
Table 117. Bayer Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Bayer Latest Developments
Table 119. PLX Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 120. PLX Pharma Piroxicam Product Offered
Table 121. PLX Pharma Main Business
Table 122. PLX Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. PLX Pharma Latest Developments
Table 124. Chiesi Details, Company Type, Piroxicam Area Served and Its Competitors
Table 125. Chiesi Piroxicam Product Offered
Table 126. Chiesi Main Business
Table 127. Chiesi Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Chiesi Latest Developments
Table 129. SK Chemicals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 130. SK Chemicals Piroxicam Product Offered
Table 131. SK Chemicals Main Business
Table 132. SK Chemicals Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. SK Chemicals Latest Developments
Table 134. Bioglan Laboratories Details, Company Type, Piroxicam Area Served and Its Competitors
Table 135. Bioglan Laboratories Piroxicam Product Offered
Table 136. Bioglan Laboratories Main Business
Table 137. Bioglan Laboratories Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Bioglan Laboratories Latest Developments
Table 139. APR Details, Company Type, Piroxicam Area Served and Its Competitors
Table 140. APR Piroxicam Product Offered
Table 141. APR Main Business
Table 142. APR Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. APR Latest Developments
Table 144. CJ HealthCare Details, Company Type, Piroxicam Area Served and Its Competitors
Table 145. CJ HealthCare Piroxicam Product Offered
Table 146. CJ HealthCare Main Business
Table 147. CJ HealthCare Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. CJ HealthCare Latest Developments
Table 149. SkyePharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 150. SkyePharma Piroxicam Product Offered
Table 151. SkyePharma Main Business
Table 152. SkyePharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. SkyePharma Latest Developments
Table 154. Changzhou Siyao Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 155. Changzhou Siyao Pharmaceutical Piroxicam Product Offered
Table 156. Changzhou Siyao Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. Changzhou Siyao Pharmaceutical Main Business
Table 158. Changzhou Siyao Pharmaceutical Latest Developments
Table 159. Shanxi Yunpeng Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 160. Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
Table 161. Shanxi Yunpeng Pharmaceutical Main Business
Table 162. Shanxi Yunpeng Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 163. Shanxi Yunpeng Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Piroxicam Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Piroxicam Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Piroxicam Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Piroxicam Sales Market Share by Country/Region (2022)
Figure 8. Piroxicam Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Piroxicam Market Size Market Share by Type in 2022
Figure 10. Piroxicam in Tendonitis
Figure 11. Global Piroxicam Market: Tendonitis (2018-2023) & ($ Millions)
Figure 12. Piroxicam in Systemic Traumatic Pain
Figure 13. Global Piroxicam Market: Systemic Traumatic Pain (2018-2023) & ($ Millions)
Figure 14. Piroxicam in Musculoskeletal Pain
Figure 15. Global Piroxicam Market: Musculoskeletal Pain (2018-2023) & ($ Millions)
Figure 16. Piroxicam in Contraception
Figure 17. Global Piroxicam Market: Contraception (2018-2023) & ($ Millions)
Figure 18. Piroxicam in Rheumatoid Arthritis
Figure 19. Global Piroxicam Market: Rheumatoid Arthritis (2018-2023) & ($ Millions)
Figure 20. Piroxicam in Chronic Infectious Arthritis
Figure 21. Global Piroxicam Market: Chronic Infectious Arthritis (2018-2023) & ($ Millions)
Figure 22. Piroxicam in Osteoarthritis
Figure 23. Global Piroxicam Market: Osteoarthritis (2018-2023) & ($ Millions)
Figure 24. Piroxicam in Other
Figure 25. Global Piroxicam Market: Other (2018-2023) & ($ Millions)
Figure 26. Global Piroxicam Market Size Market Share by Application in 2022
Figure 27. Global Piroxicam Revenue Market Share by Player in 2022
Figure 28. Global Piroxicam Market Size Market Share by Regions (2018-2023)
Figure 29. Americas Piroxicam Market Size 2018-2023 ($ Millions)
Figure 30. APAC Piroxicam Market Size 2018-2023 ($ Millions)
Figure 31. Europe Piroxicam Market Size 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Piroxicam Market Size 2018-2023 ($ Millions)
Figure 33. Americas Piroxicam Value Market Share by Country in 2022
Figure 34. United States Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 35. Canada Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 36. Mexico Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 37. Brazil Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 38. APAC Piroxicam Market Size Market Share by Region in 2022
Figure 39. APAC Piroxicam Market Size Market Share by Type in 2022
Figure 40. APAC Piroxicam Market Size Market Share by Application in 2022
Figure 41. China Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 42. Japan Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 43. Korea Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 44. Southeast Asia Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 45. India Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 46. Australia Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 47. Europe Piroxicam Market Size Market Share by Country in 2022
Figure 48. Europe Piroxicam Market Size Market Share by Type (2018-2023)
Figure 49. Europe Piroxicam Market Size Market Share by Application (2018-2023)
Figure 50. Germany Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 51. France Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 52. UK Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 53. Italy Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 54. Russia Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 55. Middle East & Africa Piroxicam Market Size Market Share by Region (2018-2023)
Figure 56. Middle East & Africa Piroxicam Market Size Market Share by Type (2018-2023)
Figure 57. Middle East & Africa Piroxicam Market Size Market Share by Application (2018-2023)
Figure 58. Egypt Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 59. South Africa Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 60. Israel Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 61. Turkey Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 62. GCC Country Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 63. Americas Piroxicam Market Size 2024-2029 ($ Millions)
Figure 64. APAC Piroxicam Market Size 2024-2029 ($ Millions)
Figure 65. Europe Piroxicam Market Size 2024-2029 ($ Millions)
Figure 66. Middle East & Africa Piroxicam Market Size 2024-2029 ($ Millions)
Figure 67. United States Piroxicam Market Size 2024-2029 ($ Millions)
Figure 68. Canada Piroxicam Market Size 2024-2029 ($ Millions)
Figure 69. Mexico Piroxicam Market Size 2024-2029 ($ Millions)
Figure 70. Brazil Piroxicam Market Size 2024-2029 ($ Millions)
Figure 71. China Piroxicam Market Size 2024-2029 ($ Millions)
Figure 72. Japan Piroxicam Market Size 2024-2029 ($ Millions)
Figure 73. Korea Piroxicam Market Size 2024-2029 ($ Millions)
Figure 74. Southeast Asia Piroxicam Market Size 2024-2029 ($ Millions)
Figure 75. India Piroxicam Market Size 2024-2029 ($ Millions)
Figure 76. Australia Piroxicam Market Size 2024-2029 ($ Millions)
Figure 77. Germany Piroxicam Market Size 2024-2029 ($ Millions)
Figure 78. France Piroxicam Market Size 2024-2029 ($ Millions)
Figure 79. UK Piroxicam Market Size 2024-2029 ($ Millions)
Figure 80. Italy Piroxicam Market Size 2024-2029 ($ Millions)
Figure 81. Russia Piroxicam Market Size 2024-2029 ($ Millions)
Figure 82. Spain Piroxicam Market Size 2024-2029 ($ Millions)
Figure 83. Egypt Piroxicam Market Size 2024-2029 ($ Millions)
Figure 84. South Africa Piroxicam Market Size 2024-2029 ($ Millions)
Figure 85. Israel Piroxicam Market Size 2024-2029 ($ Millions)
Figure 86. Turkey Piroxicam Market Size 2024-2029 ($ Millions)
Figure 87. GCC Countries Piroxicam Market Size 2024-2029 ($ Millions)
Figure 88. Global Piroxicam Market Size Market Share Forecast by Type (2024-2029)
Figure 89. Global Piroxicam Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Piroxicam Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Piroxicam Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Piroxicam Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Piroxicam Sales Market Share by Country/Region (2022)
Figure 8. Piroxicam Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Piroxicam Market Size Market Share by Type in 2022
Figure 10. Piroxicam in Tendonitis
Figure 11. Global Piroxicam Market: Tendonitis (2018-2023) & ($ Millions)
Figure 12. Piroxicam in Systemic Traumatic Pain
Figure 13. Global Piroxicam Market: Systemic Traumatic Pain (2018-2023) & ($ Millions)
Figure 14. Piroxicam in Musculoskeletal Pain
Figure 15. Global Piroxicam Market: Musculoskeletal Pain (2018-2023) & ($ Millions)
Figure 16. Piroxicam in Contraception
Figure 17. Global Piroxicam Market: Contraception (2018-2023) & ($ Millions)
Figure 18. Piroxicam in Rheumatoid Arthritis
Figure 19. Global Piroxicam Market: Rheumatoid Arthritis (2018-2023) & ($ Millions)
Figure 20. Piroxicam in Chronic Infectious Arthritis
Figure 21. Global Piroxicam Market: Chronic Infectious Arthritis (2018-2023) & ($ Millions)
Figure 22. Piroxicam in Osteoarthritis
Figure 23. Global Piroxicam Market: Osteoarthritis (2018-2023) & ($ Millions)
Figure 24. Piroxicam in Other
Figure 25. Global Piroxicam Market: Other (2018-2023) & ($ Millions)
Figure 26. Global Piroxicam Market Size Market Share by Application in 2022
Figure 27. Global Piroxicam Revenue Market Share by Player in 2022
Figure 28. Global Piroxicam Market Size Market Share by Regions (2018-2023)
Figure 29. Americas Piroxicam Market Size 2018-2023 ($ Millions)
Figure 30. APAC Piroxicam Market Size 2018-2023 ($ Millions)
Figure 31. Europe Piroxicam Market Size 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Piroxicam Market Size 2018-2023 ($ Millions)
Figure 33. Americas Piroxicam Value Market Share by Country in 2022
Figure 34. United States Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 35. Canada Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 36. Mexico Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 37. Brazil Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 38. APAC Piroxicam Market Size Market Share by Region in 2022
Figure 39. APAC Piroxicam Market Size Market Share by Type in 2022
Figure 40. APAC Piroxicam Market Size Market Share by Application in 2022
Figure 41. China Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 42. Japan Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 43. Korea Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 44. Southeast Asia Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 45. India Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 46. Australia Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 47. Europe Piroxicam Market Size Market Share by Country in 2022
Figure 48. Europe Piroxicam Market Size Market Share by Type (2018-2023)
Figure 49. Europe Piroxicam Market Size Market Share by Application (2018-2023)
Figure 50. Germany Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 51. France Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 52. UK Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 53. Italy Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 54. Russia Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 55. Middle East & Africa Piroxicam Market Size Market Share by Region (2018-2023)
Figure 56. Middle East & Africa Piroxicam Market Size Market Share by Type (2018-2023)
Figure 57. Middle East & Africa Piroxicam Market Size Market Share by Application (2018-2023)
Figure 58. Egypt Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 59. South Africa Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 60. Israel Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 61. Turkey Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 62. GCC Country Piroxicam Market Size Growth 2018-2023 ($ Millions)
Figure 63. Americas Piroxicam Market Size 2024-2029 ($ Millions)
Figure 64. APAC Piroxicam Market Size 2024-2029 ($ Millions)
Figure 65. Europe Piroxicam Market Size 2024-2029 ($ Millions)
Figure 66. Middle East & Africa Piroxicam Market Size 2024-2029 ($ Millions)
Figure 67. United States Piroxicam Market Size 2024-2029 ($ Millions)
Figure 68. Canada Piroxicam Market Size 2024-2029 ($ Millions)
Figure 69. Mexico Piroxicam Market Size 2024-2029 ($ Millions)
Figure 70. Brazil Piroxicam Market Size 2024-2029 ($ Millions)
Figure 71. China Piroxicam Market Size 2024-2029 ($ Millions)
Figure 72. Japan Piroxicam Market Size 2024-2029 ($ Millions)
Figure 73. Korea Piroxicam Market Size 2024-2029 ($ Millions)
Figure 74. Southeast Asia Piroxicam Market Size 2024-2029 ($ Millions)
Figure 75. India Piroxicam Market Size 2024-2029 ($ Millions)
Figure 76. Australia Piroxicam Market Size 2024-2029 ($ Millions)
Figure 77. Germany Piroxicam Market Size 2024-2029 ($ Millions)
Figure 78. France Piroxicam Market Size 2024-2029 ($ Millions)
Figure 79. UK Piroxicam Market Size 2024-2029 ($ Millions)
Figure 80. Italy Piroxicam Market Size 2024-2029 ($ Millions)
Figure 81. Russia Piroxicam Market Size 2024-2029 ($ Millions)
Figure 82. Spain Piroxicam Market Size 2024-2029 ($ Millions)
Figure 83. Egypt Piroxicam Market Size 2024-2029 ($ Millions)
Figure 84. South Africa Piroxicam Market Size 2024-2029 ($ Millions)
Figure 85. Israel Piroxicam Market Size 2024-2029 ($ Millions)
Figure 86. Turkey Piroxicam Market Size 2024-2029 ($ Millions)
Figure 87. GCC Countries Piroxicam Market Size 2024-2029 ($ Millions)
Figure 88. Global Piroxicam Market Size Market Share Forecast by Type (2024-2029)
Figure 89. Global Piroxicam Market Size Market Share Forecast by Application (2024-2029)
